Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Am J Kidney Dis. 2022 Feb 7;79(4):457–479. doi: 10.1053/j.ajkd.2021.09.010

Figure 1.

Figure 1.

Schematic for comprehensive care of the patient with type 2 diabetes and CKD. Recommendations from KDIGO (Kidney Disease: Improving Global Outcomes) are represented in orange. Practice points from KDIGO are represented in blue. Asterisk refers to recommendations not specifically addressed by the original schematic in the KDIGO guidelines but deemed important worthy of inclusion by the KDOQI work group. Abbreviations: CKD, chronic kidney disease; HTN, hypertension; GLP-1 RA, glucagon-like peptide 1 receptor agonist; RAS, renin-angiotensin system; MRA, mineralocorticoid receptor antagonist; SGLT2, sodium/glucose transporter 2; UACR, urinary albumin-creatinine ratio; eGFR, estimated glomerular filtration rate; BP, blood pressure.